HSBC USA Inc. has filed a pricing supplement for the issuance of Autocallable Contingent Income Barrier Notes, a financial instrument designed to attract investors by linking returns to the performance of specific stock indices. This issuance is significant as it reflects HSBC's strategy to diversify its funding sources while offering investors a unique investment opportunity.

The Autocallable Contingent Income Barrier Notes will be linked to the performance of the Nikkei Stock Average and the iShares MSCI Emerging Markets ETF. The notes are designed to provide quarterly contingent coupon payments at a rate of 2.325%, which is equivalent to an annualized rate of 9.30%, provided that the official closing value of each underlying asset meets certain performance criteria.

HSBC USA Inc. operates under the SIC code 6021, which classifies it as a national commercial bank. The company is based in New York, with its business address at 66 Hudson Boulevard. The filing, dated October 30, 2026, is part of a series of recent filings that include multiple pricing supplements and related documents.

According to the filing, the notes will not be listed on any securities exchange, and all payments are subject to the credit risk of HSBC USA Inc. Investors should note that if the least performing underlying asset declines by more than 40%, they may lose all or a portion of their principal amount.

This issuance is part of a broader trend in the banking industry, where banks are increasingly offering innovative products to attract investors amid a competitive market. The move may impact various stakeholders, including investors looking for high-yield opportunities and competitors in the national commercial banking sector.

Looking ahead, HSBC USA Inc. is expected to continue leveraging its market position to introduce similar financial products. However, the filing does not specify what happens next regarding the distribution or marketing of these notes.